Detailed Information

Cited 0 time in webofscience Cited 7 time in scopus
Metadata Downloads

Cetylpyridinium Chloride Inhibits Receptor Activator of Nuclear Factor-kappa B Ligand-Induced Osteoclast Formation

Full metadata record
DC FieldValueLanguage
dc.contributor.authorZheng, Ting-
dc.contributor.authorChen, Ling-
dc.contributor.authorNoh, A. Long Sae Mi-
dc.contributor.authorYim, Mijung-
dc.date.available2021-02-22T12:16:28Z-
dc.date.issued2013-04-
dc.identifier.issn0918-6158-
dc.identifier.issn1347-5215-
dc.identifier.urihttps://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/11308-
dc.description.abstractOsteoclasts are responsible for bone erosion in diseases as diverse as osteoporosis, periodontitis, and rheumatoid arthritis. Antiseptic products have received recent attention as potential therapeutic and preventive drugs in human disease. The purpose of this study was to investigate the effect of the antiseptic cetylpyridinium chloride (CPC) on osteoclast formation using mouse bone marrow-derived macrophages (BMMs). CPC inhibited receptor activator of nuclear factor (NF)-kappa B ligand (RANKL)-induced osteoclast formation in a dose-dependent manner without causing cytotoxicity. The mRNA expression of cathepsin K, calcitonin receptor (CTR), and Prdm1 in osteoclasts was reduced by CPC. In experiments to elucidate its mechanism of action, CPC was found to suppress RANKL-induced expression of c-Fos and nuclear factor of activated T cells (NFATc1), transcription factors that are essential for osteoclast differentiation. CPC also inhibited RANKL-induced activation of extracellular signal-regulated kinase (ERK) and NF-kappa B and expression of cyclooxygenase (COX)-2. These results collectively suggest that CPC inhibits osteoclast differentiation by suppressing the activation of ERK and NF-kappa B and reducing the expression of COX-2, c-Fos, and NFATc1. CPC may therefore be a useful drug in the prevention of bone loss.-
dc.format.extent6-
dc.language영어-
dc.language.isoENG-
dc.publisherPHARMACEUTICAL SOC JAPAN-
dc.titleCetylpyridinium Chloride Inhibits Receptor Activator of Nuclear Factor-kappa B Ligand-Induced Osteoclast Formation-
dc.typeArticle-
dc.publisher.location일본-
dc.identifier.scopusid2-s2.0-84876900921-
dc.identifier.wosid000316832500002-
dc.identifier.bibliographicCitationBIOLOGICAL & PHARMACEUTICAL BULLETIN, v.36, no.4, pp 509 - 514-
dc.citation.titleBIOLOGICAL & PHARMACEUTICAL BULLETIN-
dc.citation.volume36-
dc.citation.number4-
dc.citation.startPage509-
dc.citation.endPage514-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClasssci-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.subject.keywordPlusSIGNALING PATHWAYS-
dc.subject.keywordPlusBONE LOSS-
dc.subject.keywordPlusT-CELLS-
dc.subject.keywordPlusDIFFERENTIATION-
dc.subject.keywordPlusPRECURSORS-
dc.subject.keywordPlusEXPRESSION-
dc.subject.keywordPlusMACROPHAGES-
dc.subject.keywordPlusCROSSTALK-
dc.subject.keywordPlusINDUCTION-
dc.subject.keywordPlusIMMUNE-
dc.subject.keywordAuthorosteoporosis-
dc.subject.keywordAuthorosteoclast-
dc.subject.keywordAuthorcetylpyridinium chloride-
dc.identifier.urlhttps://www.jstage.jst.go.jp/article/bpb/36/4/36_b12-00460/_html/-char/en-
Files in This Item
Go to Link
Appears in
Collections
약학대학 > 약학부 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Yim, Mi Jung photo

Yim, Mi Jung
약학대학 (약학부)
Read more

Altmetrics

Total Views & Downloads

BROWSE